Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brp (DOO) Cash & Equivalents (2018 - 2026)

Brp (DOO) has disclosed Cash & Equivalents for 9 consecutive years, with $307.8 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents rose 141.78% to $307.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $307.8 million through Jan 2026, up 141.78% year-over-year, with the annual reading at $306.8 million for FY2026, 133.8% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $307.8 million at Brp, up from $127.3 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $363.8 million in Q1 2024, with the low at $127.3 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $231.8 million, with a median of $210.0 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents plummeted 79.62% in 2022, then soared 142.56% in 2024.
  • Over 5 years, Cash & Equivalents stood at $210.0 million in 2022, then dropped by 28.58% to $150.0 million in 2023, then skyrocketed by 142.56% to $363.8 million in 2024, then plummeted by 65.01% to $127.3 million in 2025, then skyrocketed by 141.78% to $307.8 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $307.8 million, $127.3 million, and $363.8 million for Q1 2026, Q1 2025, and Q1 2024 respectively.